Zivo Bioscience Inc. Warrants (ZIVOW) — Financial Flexibility Index
Zivo Bioscience Inc. Warrants (ZIVOW) has a Financial Flexibility Index of -1.15x as of September 2025. Free cash flow of $-266.56K (operating CF $-266.56K minus capex $0.00) represents -1% of total liabilities ($231.79K). Check how aggressively does Zivo Bioscience Inc. Warrants reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Zivo Bioscience Inc. Warrants Financial Flexibility Index (2003–2024)
Historical Financial Flexibility Index trend for Zivo Bioscience Inc. Warrants across 22 annual periods. For the full cash flow conversion analysis, see Zivo Bioscience Inc. Warrants cash flow conversion.
Annual Financial Flexibility Index for Zivo Bioscience Inc. Warrants (2003–2024)
Year-by-year free cash flow to debt coverage for Zivo Bioscience Inc. Warrants. Explore ZIVOW cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -2.00x | $-4.31 Million | $-4.31 Million | $2.16 Million | ▲ +4.8% |
| 2023 | -2.10x | $-5.80 Million | $-5.80 Million | $2.76 Million | ▲ +36.9% |
| 2022 | -3.33x | $-7.10 Million | $-7.10 Million | $2.13 Million | ▼ -44.2% |
| 2021 | -2.31x | $-6.80 Million | $-6.80 Million | $2.95 Million | ▼ -928.1% |
| 2020 | -0.22x | $-2.59 Million | $-2.59 Million | $11.53 Million | ▲ +47.3% |
| 2019 | -0.43x | $-3.71 Million | $-3.71 Million | $8.71 Million | ▼ -93.0% |
| 2018 | -0.22x | $-5.01 Million | $-5.01 Million | $22.69 Million | ▼ -6.7% |
| 2017 | -0.21x | $-4.24 Million | $-4.24 Million | $20.51 Million | ▼ -16.8% |
| 2016 | -0.18x | $-2.54 Million | $-2.54 Million | $14.36 Million | ▲ +26.2% |
| 2015 | -0.24x | $-2.30 Million | $-2.30 Million | $9.57 Million | ▲ +43.2% |
| 2014 | -0.42x | $-2.74 Million | $-2.74 Million | $6.47 Million | ▼ -87.4% |
| 2013 | -0.23x | $-2.65 Million | $-2.99 Million | $11.77 Million | ▲ +46.6% |
| 2012 | -0.42x | $-1.77 Million | $-1.77 Million | $4.19 Million | ▲ +18.3% |
| 2011 | -0.52x | $-1.29 Million | $-1.29 Million | $2.49 Million | ▲ +52.7% |
| 2010 | -1.09x | $-1.41 Million | $-1.44 Million | $1.29 Million | ▼ -302.5% |
| 2009 | -0.27x | $-1.14 Million | $-1.15 Million | $4.19 Million | ▲ +68.3% |
| 2008 | -0.85x | $-816.07K | $-935.82K | $954.74K | ▲ +37.2% |
| 2007 | -1.36x | $-1.40 Million | $-1.41 Million | $1.03 Million | ▲ +20.0% |
| 2006 | -1.70x | $-1.97 Million | $-2.09 Million | $1.15 Million | ▼ -30.4% |
| 2005 | -1.31x | $-1.63 Million | $-1.65 Million | $1.25 Million | ▼ -17.9% |
| 2004 | -1.11x | $-1.28 Million | $-1.28 Million | $1.16 Million | ▼ -191.6% |
| 2003 | -0.38x | $-17.39K | $-17.39K | $45.78K | — |